BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3
18 results:

  • 1. Demethylation of CADM1 and socs1 using capsaicin in cervical cancer cell line.
    Sharan M; Jha M; Chandel R; Syeda S; Mathur R; Jha NK; Jha SK; Goel H; Shrivastava A; Chauhan S; Pamidimarri S; Jha AK
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Apr; 396(4):649-657. PubMed ID: 36441265
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pathways of IFN-alpha Activation in Patients with cervical Intraepithelial Neoplasia (CIN).
    Tirone NR; Campos CG; Ferreira KJA; Stark LM; Vieira JF; Murta EFC; Michelin MA
    Rev Bras Ginecol Obstet; 2021 Sep; 43(9):682-689. PubMed ID: 34670303
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels.
    Zhou C; Wei W; Ma J; Yang Y; Liang L; Zhang Y; Wang Z; Chen X; Huang L; Wang W; Wu S
    Mol Ther; 2021 Apr; 29(4):1512-1528. PubMed ID: 33388421
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A lipid-soluble extract of Pinellia pedatisecta Schott orchestrates intratumoral dendritic cell-driven immune activation through socs1 signaling in cervical cancer.
    Wang Y; Lu C; Huang H; Yao S; Xu C; Ye Y; Gui S; Li G
    J Ethnopharmacol; 2021 Mar; 267():112837. PubMed ID: 32276009
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MiR-155 promotes anaplastic thyroid cancer progression by directly targeting socs1.
    Zhang W; Ji W; Zhao X
    BMC Cancer; 2019 Nov; 19(1):1093. PubMed ID: 31718618
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting socs1 in cervical cancer.
    Zeng YT; Liu XF; Yang WT; Zheng PS
    Oncogene; 2019 Oct; 38(43):6940-6957. PubMed ID: 31409905
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MiR-29a inhibits invasion and metastasis of cervical cancer via modulating methylation of tumor suppressor socs1.
    Gong Y; Wan JH; Zou W; Lian GY; Qin JL; Wang QM
    Future Oncol; 2019 May; 15(15):1729-1744. PubMed ID: 31038361
    [No Abstract]    [Full Text] [Related]  

  • 8. MicroRNA-155 regulates cervical cancer via inducing Th17/Treg imbalance.
    Zhang Y; Wang ZC; Zhang ZS; Chen F
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3719-3726. PubMed ID: 29949145
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association between methylation of tumor suppressor gene socs1 and acute myeloid leukemia.
    Zhang XH; Yang L; Liu XJ; Zhan Y; Pan YX; Wang XZ; Luo JM
    Oncol Rep; 2018 Aug; 40(2):1008-1016. PubMed ID: 29916533
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Dendritic cells infected by Ad-sh-socs1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models.
    Zheng Y; Hu B; Xie S; Chen X; Hu Y; Chen W; Li S; Hu B
    Cytotherapy; 2017 May; 19(5):617-628. PubMed ID: 28215653
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation and histone deacetylation and regulate response to radiotherapy in cervical cancer cells.
    Kim MH; Kim MS; Kim W; Kang MA; Cacalano NA; Kang SB; Shin YJ; Jeong JH
    PLoS One; 2015; 10(4):e0123133. PubMed ID: 25849377
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. MiR-122 directly inhibits human papillomavirus E6 gene and enhances interferon signaling through blocking suppressor of cytokine signaling 1 in SiHa cells.
    He J; Ji Y; Li A; Zhang Q; Song W; Li Y; Huang H; Qian J; Zhai A; Yu X; Zhao J; Shang Q; Wei L; Zhang F
    PLoS One; 2014; 9(9):e108410. PubMed ID: 25265013
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Enhanced immunotherapeutic effect of modified HPV16 E7-pulsed dendritic cell vaccine by an adeno-shRNA-socs1 virus.
    Zhu Y; Zheng Y; Mei L; Liu M; Li S; Xiao H; Zhu H; Wu S; Chen H; Huang L
    Int J Oncol; 2013 Oct; 43(4):1151-9. PubMed ID: 23877655
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Reaching teenagers with three-times jab is a first for most countries.
    Adams P
    Bull World Health Organ; 2012 Dec; 90(12):874-5. PubMed ID: 23284191
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis.
    Sobti RC; Singh N; Hussain S; Suri V; Nijhawan R; Bharti AC; Bharadwaj M; Das BC
    Cell Oncol (Dordr); 2011 Dec; 34(6):533-43. PubMed ID: 21935712
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes.
    Volante R; Giubilato P; Ronco G
    Epidemiol Prev; 2008; 32(2 Suppl 1):69-76. PubMed ID: 18773525
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. socs1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein.
    Kamio M; Yoshida T; Ogata H; Douchi T; Nagata Y; Inoue M; Hasegawa M; Yonemitsu Y; Yoshimura A
    Oncogene; 2004 Apr; 23(17):3107-15. PubMed ID: 15021916
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.